Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
We also doubled down on existing Portfolio companies that had sold off by more than any change in the underlying business justified (e.g., Roche Holdings AG, Alfa Laval AG) and sold some companies that couldn’t offer the same risk-reward profile as the businesses we were gifted in that short window.
— Sydney Van Vierzen
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Roche Holding AG
No other institutional pitches found for this ticker yet.
More institutional theses from EdgePoint Global
Thermo Fisher functions as a leading end-to-end platform in the life sciences sector with exceptional scale and reliable performance. The manager leveraged...
The manager originally expected massive growth from Lincoln Electric's EV-charging network potential, but bureaucratic delays and a new administration killed the program. Despite the growth...
Dollar Tree has successfully transitioned to a multi-price point model by moving away from its strict one-dollar limit. This shift provides...